Suicide risk in people with epilepsy taking antiepileptic drugs

  title={Suicide risk in people with epilepsy taking antiepileptic drugs},
  author={Marco Mula and Josemir W Sander},
  journal={Bipolar Disorders},
  pages={622 - 627}
The standardized mortality ratio for suicide in people with epilepsy is reported as 5.1 [95% confidence interval (CI): 3.9–6.6], but this is only partially explained by the high rates of psychiatric comorbidity. This issue was revived when, in 2008, the Food and Drug Administration (FDA) issued an alert on an increased risk of suicide in people taking antiepileptic drugs (AEDs). We discuss and elaborate on available evidence on the interplay among epilepsy, suicide, and AEDs, taking into… 

Is antiepileptic-induced suicidality a data-based class effect or an exaggeration? A comment on the literature.

Clinicians need to carefully assess suicidality in all patients treated with AEDs and inform them and their families on the possible increased risk of suicideality, though preferably in a way that keeps open the continuing use of Aeds.

Severity features of suicide attempters with epilepsy.

A Need for Personalised Suicidology: Pharmacoepidemiology

This review investigates the impact of drugs on suicide risk in specific populations and the characteristics associated with an increased risk for the various therapeutic classes on the basis of the available data.

Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy

Analysis of the data revealed that the data are not supportive of the presence of a “class effect” on suicide-related behavior, but there are some data suggesting such an effect concerning treatment with topiramate, lamotrigine, and levetiracetam for which further research is needed.

Suicidality and Its Risk Factors in Korean People with Epilepsy: A MEPSY Study

Clinicians should monitor psychiatric disorders and the adverse effects of AEDs in PWE in an attempt to reduce the incidence of suicidal ideation or suicide attempts in this patient population.

Neurobiological Basis of Increased Risk for Suicidal Behaviour

The etiopathogenesis of suicide behaviour is presented and the mechanisms of action of anti-suicidal treatments are explored, pinpointing similarities among them.

Diagnosing and treating depression in epilepsy

Pharmacological and non-pharmacological approaches to life threatening conditions in epilepsy

Although a possible link between taking AEDs and increased suicidality is questionable, patients with epilepsy are advised to be evaluated for possible symptoms of depression or anxiety and surgical treatment of epilepsy may increase the risk of depression development.

Epilepsy and its management in relation to Psychiatry

This paper aimed to review psychiatric presentations in individuals with epilepsy and the adverse psychiatric effects of antiepileptic medications and briefly discusses available treatment options with regards of better psychotropic treatment options.

Antisuicidal Effects in Mood Disorders: Are They Unique to Lithium?

Substantial reduction of risks of suicide and attempts with long-term lithium treatment, particularly in depressive phases of BD and in MDD, and in mixed (agitated-dysphoric) states than in manic or hypomanic periods.



Suicidality in People Taking Antiepileptic Drugs

The risk of suicidal ideation and behaviour as adverse effects of AED treatment, although increased, seems low and alert clinicians are supposed to inform patients and their families of this increased risk but it is important to place it in a proper perspective.

Suicidal behavior and antiepileptic drugs in epilepsy: analysis of the emerging evidence

Risks associated with stopping, or not even starting, AEDs in epilepsy might well be in excess of the risk of suicide in epilepsy, as deaths due to accident and epilepsy itself may predominate.

Antiepileptic drugs and risk of suicide: a nationwide study

Patients with epilepsy or psychiatric diseases have increased risk of suicide, but whether the risk is influenced by antiepileptic drug (AED) treatment is unclear. Studies have suggested that AEDs in

Suicide-related events in patients treated with antiepileptic drugs.

The current use of antiepileptic drugs was not associated with an increased risk of suicide-related events among patients with epilepsy, but it was associated with a increase risk of such events among Patients with depression and among those who did not have epilepsy, depression, or bipolar disorder.

Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior

Newer AEDs with a rather high frequency of depressive symptoms in clinical trials may also increase the risk of self-harm or suicidal behavior in clinical practice, according to an observational study in a cohort of 44,300 patients with epilepsy.

Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder.

Despite Food and Drug Administration reports regarding increased risk of suicidality associated with AED treatment, the current study reveals that, as a class, AEDs do not increase risk of suicide attempts in patients with bipolar disorder relative to patients not treated with an AED or lithium.

Antiepileptic drugs and suicidality: An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology

Although some (but not all) AEDs can be associated with treatment‐emergent psychiatric problems that can lead to suicidal ideation and behavior, the actual suicidal risk is yet to be established, but it seems to be very low.

Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy

Individuals with a personal or family history of depression should be carefully followed after initiation of therapy with a new antiepileptic drug, especially if structural brain abnormalities such as hippocampal sclerosis are present.

Mortality of Epilepsy in Developed Countries: A Review

There was up to a threefold increase in mortality in population‐based incidence cohorts of epilepsy with 7–29 years follow-up, compared to the general population when studies include selected epilepsy populations where patients with frequent and severe seizures are more common.

The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?

It is recommended that all patients with epilepsy be routinely evaluated for depression, anxiety, and suicidality, and that future clinical trials include validated instruments to systematically assess these conditions to determine whether the possible signal observed by the FDA is real.